Unique Benefits
- The QuantiGene Plex 2.0 Assay provides DIRECT from lysate measurement of 3 to 80 target RNAs per well with unparalleled accuracy and precision.
- Quantitatively measure multiple RNA targets simultaneously with unparalleled accuracy and precision
- Quantitation of original RNA population directly from lysates avoids biases, sample loss, false positive/negative results associated with
- RNA isolation
- cDNA synthesis
- PCR amplification
- RNA isolation
- High accuracy and precision using branch DNA (bDNA) signal amplification versus target amplification (PCR)
- High precision - coefficient of variation (CV) of less than 15% for entire process (sample isolation to results)
- High accuracy - distinguish percentage differences in RNA copy nmber - linear assay with low CVs
- No optimization required for multiplexing 3 to 80 target RNAs
- Excellent results in difficult clinical research samples, including, H&E-stained FFPE, blood, and skin
Accurate results in a variety of samples
- Compatible with human, animal and plant tissues, FFPE tissue sections, whole blood, Tempus blood, PAXgene blood, cultured cells, isolated RNA and more
Validated panels
- Each panel is functionally validated
Applications
- Validation and testing of disease biomarkers (e.g. cancer, neurology, autoimmune disease, etc.)
- Validation of microarray or sequencing results
- Predictive toxicology
- Secondary screening
- Pathway analysis
QuantiGene Plex 2.0 Assay Specifications
|
